Assessment of fibroblast growth factor 19 as a non-invasive serum marker for hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessment of fibroblast growth factor 19 as a non-invasive serum marker for hepatocellular carcinoma

Published:2022-03-27 Issue:3 Volume:14 Page:623-633
ISSN:1948-5182
Container-title:World Journal of Hepatology
language:
Short-container-title:WJH

Author:

Mohamed Ghada Abdelrahman,Nashaat Ehab Hasan,Fawzy Hadeer Mohamed,ElGhandour Ahmed Mohamed

Publisher

Baishideng Publishing Group Inc.

Subject

Hepatology

Reference38 articles.

1. Fibroblast growth factor 19-targeted therapies for the treatment of metabolic disease

2. Decrease of FGF19 contributes to the increase of fasting glucose in human in an insulin-independent manner

3. An Overview of FGF19 and FGF21: The Therapeutic Role in the Treatment of the Metabolic Disorders and Obesity

4. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss

5. Targeting FGF19/FGFR4 Pathway: A Novel Therapeutic Strategy for Hepatocellular Carcinoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of FGF19 in metabolic regulation: insights from preclinical models to clinical trials;American Journal of Physiology-Endocrinology and Metabolism;2024-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP